SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 298 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,000 | -11.1% | 263 | -6.4% | 0.01% | +200.0% |
| Q1 2022 | $9,000 | +28.6% | 281 | +23.2% | 0.00% | +100.0% |
| Q4 2021 | $7,000 | +16.7% | 228 | +2.7% | 0.00% | 0.0% |
| Q3 2021 | $6,000 | -25.0% | 222 | -17.8% | 0.00% | -50.0% |
| Q2 2021 | $8,000 | 0.0% | 270 | -14.8% | 0.00% | 0.0% |
| Q1 2021 | $8,000 | +100.0% | 317 | +84.3% | 0.00% | +100.0% |
| Q4 2020 | $4,000 | -20.0% | 172 | -29.8% | 0.00% | 0.0% |
| Q3 2020 | $5,000 | +25.0% | 245 | +33.9% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | 0.0% | 183 | -25.0% | 0.00% | 0.0% |
| Q1 2020 | $4,000 | -50.0% | 244 | -32.6% | 0.00% | -50.0% |
| Q4 2019 | $8,000 | -20.0% | 362 | +3.1% | 0.00% | 0.0% |
| Q3 2019 | $10,000 | -88.0% | 351 | -74.5% | 0.00% | -89.5% |
| Q2 2019 | $83,000 | +260.9% | 1,379 | +108.0% | 0.02% | +375.0% |
| Q1 2019 | $23,000 | -20.7% | 663 | -24.5% | 0.00% | -33.3% |
| Q4 2018 | $29,000 | -44.2% | 878 | -16.2% | 0.01% | -40.0% |
| Q3 2018 | $52,000 | -36.6% | 1,048 | -24.0% | 0.01% | -44.4% |
| Q2 2018 | $82,000 | +54.7% | 1,379 | +18.5% | 0.02% | +50.0% |
| Q1 2018 | $53,000 | +17.8% | 1,164 | +3.2% | 0.01% | +9.1% |
| Q4 2017 | $45,000 | – | 1,128 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $17,478,000 | 3.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,124,405 | $36,341,000 | 3.91% |
| ARMISTICE CAPITAL, LLC | 3,100,000 | $100,192,000 | 1.94% |
| S&T BANK/PA | 316,326 | $10,224,000 | 1.54% |
| Bruce & Co., Inc. | 222,105 | $7,178,000 | 1.47% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 379,875 | $12,278,000 | 1.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 854,949 | $27,632,000 | 1.10% |
| Soleus Capital Management, L.P. | 251,000 | $8,112,000 | 1.05% |
| Parkman Healthcare Partners LLC | 108,954 | $3,521,000 | 1.03% |
| Aristotle Capital Boston, LLC | 1,258,067 | $40,661,000 | 1.03% |